
Professional Acne Medication Market by Acne Type (Inflammatory Acne and Non-inflammatory Acne), by Formulation (Topical Medications and Oral Medications), by Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, and Others), and by
Description
Professional Acne Medication Market by Acne Type (Inflammatory Acne and Non-inflammatory Acne), by Formulation (Topical Medications and Oral Medications), by Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, and Others), and by Distribution Channel (Med Spa, Aesthetician, Dermatologist, and Other Professional Channels) – Global Opportunity Analysis and Industry Forecast, 2024–2030
Meta Des: Professional acne medication market was valued at USD 3.22 Bn in 2023, and is predicted to reach USD 5.23 Bn by 2030, driven by the increasing incidence of acne vulgaris among both teenagers and adults.
Professional Acne Medication Market
Domain – Consumer Goods
Sub Domain – Personal Care Products
The professional acne medication market size was valued at USD 3.22 billion in 2023, and is projected to reach USD 5.23 billion by 2030, with a CAGR of 7.2% during the forecast period, 2024–2030.
The professional acne medication market is growing due to the increasing occurrence of acne in both teenagers and adults. A survey by Yale Medicine revealed that about half of women in their 20s, one-third of women in their 30s, and a quarter of women in their 40s experience acne. Several factors contributing to this include high-stress levels, poor diet, disrupted sleep patterns, and environmental pollution. Hormonal changes during puberty in teenagers and various life stages in adults also lead to acne breakouts. Rising awareness of the psychological and physical effects of acne along with the influence of social media on self-image motivated individuals to seek professional dermatological solutions.
Moreover, modern lifestyles marked by elevated stress levels, unhealthy dietary choices, disrupted sleep patterns, and sedentary habits have increased acne cases. These factors are expected to continue driving the demand for professional acne medication. Furthermore, ongoing developments in dermatological technology and treatment options are boosting the market. These include innovative therapies, personalized treatment plans, and a focus on minimizing side effects. For instance, In March 2022, the U.S. Food and Drug Administration (FDA) granted its initial 510(k) clearance for an energy-based device designed to treat various levels of acne ranging from mild to severe. This therapy has garnered considerable attention in recent years as one of the most extensively studied light-based treatments for acne.
In addition, the deteriorating quality of the environment, including exposure to air pollution, can worsen skin conditions and exacerbate acne. This environmental impact will boost the market as individuals seek effective solutions.
However, the expenses associated with professional acne medication, including consultations, prescriptions, and treatments, can be a significant barrier to adoption, particularly for individuals without comprehensive health insurance coverage. This high cost of treatment is expected to restrain the growth of the professional acne medication industry.
On the contrary, the growing utilization of telemedicine and virtual consultations represents a promising opportunity for the future of the professional acne medication market. These digital healthcare solutions can extend the reach of dermatologists and skincare professionals, making professional acne treatment more accessible in remote or underserved regions. As telemedicine continues to evolve, it allows individuals who might have previously faced geographical barriers to connect with specialists, seek expert advice, and receive tailored acne treatment plans. This factor, in turn, drives the growth of the professional acne medication market.
Segment Overview
The global professional acne medication market is segmented on the basis of acne type, formulation, therapeutic class, distribution channel, and region.
Based on acne type, the market is bifurcated into inflammatory acne and non-inflammatory acne.
Based on formulation, the market is segmented into topical medications and oral medications.
Based on therapeutic class, the market is categorized into retinoids, antibiotics, salicylic acid, benzoyl peroxide, and others.
Based on distribution channel, the market is segmented into med spa, aesthetician, dermatologist, and other professional channels.
Based on region, the market is segmented into North America, Europe, Asia-Pacific, and the rest of the world (RoW).
Regional Analysis
North America holds the dominant market share in the global professional acne medication market
North America stands at the forefront of the global professional acne medication market, holding an impressive 47% global share. This prominence is related to the ongoing expansion of the dermatology field. With an increasing number of highly-skilled professionals specializing in skin conditions including acne, the region is witnessing a surge in accessible and advanced treatment options for acne patients. As of 2022, the U.S. Bureau of Labor Statistics estimated a total of 11,640 dermatologists employed in the U.S. who are proficient in offering a range of medical and dermatological treatments. This growing pool of experts improves the availability of specialized care and raises awareness about cutting-edge acne treatment solutions.
Moreover, the professional acne medication industry in the U.S. is undergoing remarkable growth, due to the integration of advanced technology by dermatologists and skincare professionals. This tech infusion has advanced a range of new diagnostic tools and treatment procedures, including telemedicine for virtual consultations, 3D skin imaging, and AI-powered skincare analysis. For example, Cetaphil, a renowned sensitive skincare brand in the U.S., introduced an innovative AI-powered skin analysis tool in March 2023. This tool is designed to provide customers with personalized advice and product recommendations based on their unique skin needs, encompassing concerns including acne, redness, hydration, dark spots, and wrinkles. This technological advancement drives the growth of the professional acne medication market by fostering heightened interest and demand for personalized and high-quality acne treatments.
Key Market Players
Leading players operating in the professional acne medication industry include:
• Almirall SA
• Bausch Health Companies, Inc.
• GlaxoSmithKline Plc (GSK)
• Galderma SA
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries Ltd.
• Johnson & Johnson
• STRATA Skin Sciences, Inc.
• Mayne Pharma Group Ltd.
• Pfizer, Inc.
Recent Developments
October 2023
Teva Pharmaceutical Industries announced plans to collaborate with French drugmaker Sanofi to develop a treatment for inflammatory bowel disease. This collaboration strengthens the company’s commitment to advance innovative treatment options for inflammatory conditions with an increasing unmet demand for acne, dermatitis, and others.
May 2023
Ortho Dermatologics, the dermatology business of Bausch Health Companies, Inc., announced the FDA clearance of the New Drug Application (NDA) for investigational IDP-126 Gel with a Prescription Drug User Fee Act (PDUFA). This developmental strategy is expected to bring a first-of-its-kind triple-combination acne treatment to millions suffering from acne.
July 2022
STRATA Skin Sciences, Inc., a medical technology company, commercially launched TheraClearX. This launch is an in-office and non-invasive acne treatment targeting the root causes of mild to moderate acne, including comedonal, pustular, and inflammatory acne vulgaris. This technology will offer an exciting new treatment option for acne patients and dermatology professionals.
July 2022
Almirall, S.A., a global biopharmaceutical company specializing in skin health, introduced an open innovation platform for soliciting collaboration proposals in the field of dermatological research. This initiative is designed to discover fresh partnership prospects for assets in the preclinical or clinical development stages, potentially leading to novel treatments for skin diseases.
March 2022
Galderma unveiled TWYNEO (tretinoin and benzoyl peroxide) Cream, 0.1%/3%, during the American Academy of Dermatology (AAD) Annual Meeting in the U. S. Its the sole 2-in-1 combination featuring 0.1% tretinoin and 3% benzoyl peroxide (BPO) proven to effectively and quickly treat moderate to severe facial acne.
KEY BENEFITS
• The professional acne medication market report provides a quantitative analysis of the current market and estimations from 2024 to 2030. This analysis assists in identifying the prevailing market opportunities to capitalize on.
• The study comprises a detailed analysis of the professional acne medication market trends, including the current and future trends to depict prevalent investment pockets in the market.
• The information related to key drivers, restraints, and opportunities and their impact on the professional acne medication market is provided in the report.
• The competitive analysis of the market players along with their market share in the professional acne medication market is provided in the report.
• The SWOT analysis and Porter's Five Forces model are elaborated in the study.
• The value chain analysis in the market study provides a clear picture of the roles of stakeholders.
Table of Contents
400 Pages
- 1. Introduction
- 1.1. Report Description
- 1.2. Who Should Read This Report
- 1.3. Key Market Segments
- 1.4. Research Methodology
- 1.4.1 Secondary Research
- 1.4.2 Data Analysis Framework
- 1.4.3 Market Size Estimation
- 1.4.4 Forecasting
- 1.4.5 Primary Research And Data Validation
- 2. Professional Acne Medication Market – Executive Summary
- 2.1. Market Snapshot, 2022 - 2030, Million Usd
- 3. Market Overview
- 3.1. Market Definition And Scope
- 3.2. Market Dynamics
- 3.2.1 Drivers
- 3.2.1.1. Unhealthy Food Habits And Rise In Sedentary Lifestyles
- 3.2.1.2. Occurrence Of Acne Vulgaris Condition In Teenagers & Adults
- 3.2.1.3. Rising Consciousness About The Overall Appearance, Health, And Attire
- 3.2.2 Restraints
- 3.2.2.1. Side-effects Related With The Usage Of Acne Medications And Substitute Acne Treatment Options
- 3.2.3 Opportunities
- 3.2.3.1. Emergence & Development Of Effective Acne Medications With Minor Side Effects
- 3.2.3.2. Significant Market Potential In Untapped Developing Countries
- 4. Covid-19 Analysis
- 4.1. Impact On Market Size
- 4.2. End User Trends & Preferences, And Budget & Economic Impact
- 4.3. Key Player Strategies To Tackle Covid-19’s Influence On Market
- 5. Market Share Analysis
- 5.1. Market Share Analysis Of Top Acne Medication Providers, 2020
- 6. Total Number Of Medical Spas By Country
- 7. Global Professional Acne Medication Market, By Distribution Channels
- 7.1. Overview
- 7.2. Med Spa
- 7.2.1 Med Spa Market, By Region
- 7.2.1.1. North America Med Spa Market, By Country
- 7.2.1.2. Europe Med Spa Market, By Country
- 7.2.1.3. Asia-pacific Med Spa Market, By Country
- 7.2.1.4. Rest Of World Med Spa Market, By Country
- 7.3. Estheticians
- 7.3.1 Estheticians Market, By Region
- 7.3.1.1. North America Estheticians Market, By Country
- 7.3.1.2. Europe Estheticians Market, By Country
- 7.3.1.3. Asia-pacific Estheticians Market, By Country
- 7.3.1.4. Rest Of World Estheticians Market, By Country
- 7.4. Dermatologist
- 7.4.1 Dermatologist Market, By Region
- 7.4.1.1. North America Dermatologist Market, By Country
- 7.4.1.2. Europe Dermatologist Market, By Country
- 7.4.1.3. Asia-pacific Dermatologist Market, By Country
- 7.4.1.4. Rest Of World Dermatologist Market, By Country
- 7.5. Other Professional Channels
- 7.5.1 Other Professional Channels Market, By Region
- 7.5.1.1. North America Other Professional Channels Market, By Country
- 7.5.1.2. Europe Other Professional Channels Market, By Country
- 7.5.1.3. Asia-pacific Other Professional Channels Market, By Country
- 7.5.1.4. Rest Of World Other Professional Channels Market, By Country
- 8. Global Professional Acne Medication Market, By Acne Type
- 8.1. Overview
- 8.2. Inflammatory Acne
- 8.2.1 Inflammatory Acne Market, By Region
- 8.2.1.1. North America Inflammatory Acne Market, By Country
- 8.2.1.2. Europe Inflammatory Acne Market, By Country
- 8.2.1.3. Asia-pacific Inflammatory Acne Market, By Country
- 8.2.1.4. Rest Of World Inflammatory Acne Market, By Country
- 8.3. Non-inflammatory Acne
- 8.3.1 Non-inflammatory Acne Market, By Region
- 8.3.1.1. North America Non-inflammatory Acne Market, By Country
- 8.3.1.2. Europe Non-inflammatory Acne Market, By Country
- 8.3.1.3. Asia-pacific Non-inflammatory Acne Market, By Country
- 8.3.1.4. Rest Of World Non-inflammatory Acne Market, By Country
- 9. Global Professional Acne Medication Market, By Therapeutic Class
- 9.1. Overview
- 9.2. Retinoids
- 9.2.1 Global Retinoids Market, By Therapeutic Class
- 9.2.1.1. Topical Retinoid & Combination Retionoid Market, By Region
- 9.2.1.1.1. North America Topical Retinoid & Combination Retionoid Market, By Country
- 9.2.1.1.2. Europe Topical Retinoid & Combination Retionoid Market, By Country
- 9.2.1.1.3. Asia-pacific Topical Retinoid & Combination Retionoid Market, By Country
- 9.2.1.1.4. Rest Of World Topical Retinoid & Combination Retionoid Market, By Country
- 9.2.1.2. Oral Retinoid (Isoretinion) Market, By Region
- 9.2.1.2.1. North America Oral Retinoid (Isoretinion) Market, By Country
- 9.2.1.2.2. Europe Oral Retinoid (Isoretinion) Market, By Country
- 9.2.1.2.3. Asia-pacific Oral Retinoid (Isoretinion) Market, By Country
- 9.2.1.2.4. Rest Of World Oral Retinoid (Isoretinion) Market, By Country
- 9.2.2 Retinoids Market, By Region
- 9.2.2.1. North America Retinoids Market, By Country
- 9.2.2.2. Europe Retinoids Market, By Country
- 9.2.2.3. Asia-pacific Retinoids Market, By Country
- 9.2.2.4. Rest Of World Retinoids Market, By Country
- 9.3. Antibiotics
- 9.3.1 Global Antibiotics Market, By Therapeutic Class
- 9.3.1.1. Topical Antibiotic & Combination Antibiotics Market, By Region
- 9.3.1.1.1. North America Topical Antibiotic & Combination Antibiotics Market, By Country
- 9.3.1.1.2. Europe Topical Antibiotic & Combination Antibiotics Market, By Country
- 9.3.1.1.3. Asia-pacific Topical Antibiotic & Combination Antibiotics Market, By Country
- 9.3.1.1.4. Rest Of World Topical Antibiotic & Combination Antibiotics Market, By Country
- 9.3.1.2. Oral Antibiotic Market, By Region
- 9.3.1.2.1. North America Oral Antibiotic Market, By Country
- 9.3.1.2.2. Europe Oral Antibiotic Market, By Country
- 9.3.1.2.3. Asia-pacific Oral Antibiotic Market, By Country
- 9.3.1.2.4. Rest Of World Oral Antibiotic Market, By Country
- 9.3.2 Antibiotics Market, By Region
- 9.3.2.1. North America Antibiotics Market, By Country
- 9.3.2.2. Europe Antibiotics Market, By Country
- 9.3.2.3. Asia-pacific Antibiotics Market, By Country
- 9.3.2.4. Rest Of World Antibiotics Market, By Country
- 9.4. Salicylic Acid
- 9.4.1 Salicylic Acid Market, By Region
- 9.4.1.1. North America Salicylic Acid Market, By Country
- 9.4.1.2. Europe Salicylic Acid Market, By Country
- 9.4.1.3. Asia-pacific Salicylic Acid Market, By Country
- 9.4.1.4. Rest Of World Salicylic Acid Market, By Country
- 9.5. Benzoyl Peroxide
- 9.5.1 Benzoyl Peroxide Market, By Region
- 9.5.1.1. North America Benzoyl Peroxide Market, By Country
- 9.5.1.2. Europe Benzoyl Peroxide Market, By Country
- 9.5.1.3. Asia-pacific Benzoyl Peroxide Market, By Country
- 9.5.1.4. Rest Of World Benzoyl Peroxide Market, By Country
- 9.6. Others
- 9.6.1 Others Market, By Region
- 9.6.1.1. North America Others Market, By Country
- 9.6.1.2. Europe Others Market, By Country
- 9.6.1.3. Asia-pacific Others Market, By Country
- 9.6.1.4. Rest Of World Others Market, By Country
- 10. Global Professional Acne Medication Market, By Formulation
- 10.1. Overview
- 10.2. Topical Medications
- 10.2.1 Topical Medications Market, By Region
- 10.2.1.1. North America Topical Medications Market, By Country
- 10.2.1.2. Europe Topical Medications Market, By Country
- 10.2.1.3. Asia-pacific Topical Medications Market, By Country
- 10.2.1.4. Rest Of World Topical Medications Market, By Country
- 10.3. Oral Medications
- 10.3.1 Oral Medications Market, By Region
- 10.3.1.1. North America Oral Medications Market, By Country
- 10.3.1.2. Europe Oral Medications Market, By Country
- 10.3.1.3. Asia-pacific Oral Medications Market, By Country
- 10.3.1.4. Rest Of World Oral Medications Market, By Country
- 11. Global Professional Acne Medication Market, By Region
- 11.1. Overview
- 11.2. North America
- 11.2.1 North America Professional Acne Medication Market, By Distribution Channels
- 11.2.2 North America Professional Acne Medication Market, By Acne Type
- 11.2.3 North America Professional Acne Medication Market, By Therapeutic Class
- 11.2.3.1. North America Retinoids Market, By Therapeutic Class
- 11.2.3.2. North America Antibiotics Market, By Therapeutic Class
- 11.2.4 North America Professional Acne Medication Market, By Formulation
- 11.2.5 North America Professional Acne Medication Market, By Country
- 11.2.5.1. U.S.
- 11.2.5.1.1. U.S. Professional Acne Medication Market, By Distribution Channels
- 11.2.5.1.2. U.S. Professional Acne Medication Market, By Acne Type
- 11.2.5.1.3. U.S. Professional Acne Medication Market, By Therapeutic Class
- 11.2.5.1.3.1. U.S. Retinoids Market, By Therapeutic Class
- 11.2.5.1.3.2. U.S. Antibiotics Market, By Therapeutic Class
- 11.2.5.1.4. U.S. Professional Acne Medication Market, By Formulation
- 11.2.5.2. Canada
- 11.2.5.2.1. Canada Professional Acne Medication Market, By Distribution Channels
- 11.2.5.2.2. Canada Professional Acne Medication Market, By Acne Type
- 11.2.5.2.3. Canada Professional Acne Medication Market, By Therapeutic Class
- 11.2.5.2.3.1. Canada Retinoids Market, By Therapeutic Class
- 11.2.5.2.3.2. Canada Antibiotics Market, By Therapeutic Class
- 11.2.5.2.4. Canada Professional Acne Medication Market, By Formulation
- 11.2.5.3. Mexico
- 11.2.5.3.1. Mexico Professional Acne Medication Market, By Distribution Channels
- 11.2.5.3.2. Mexico Professional Acne Medication Market, By Acne Type
- 11.2.5.3.3. Mexico Professional Acne Medication Market, By Therapeutic Class
- 11.2.5.3.3.1. Mexico Retinoids Market, By Therapeutic Class
- 11.2.5.3.3.2. Mexico Antibiotics Market, By Therapeutic Class
- 11.2.5.3.4. Mexico Professional Acne Medication Market, By Formulation
- 11.3. Europe
- 11.3.1 Europe Professional Acne Medication Market, By Distribution Channels
- 11.3.2 Europe Professional Acne Medication Market, By Acne Type
- 11.3.3 Europe Professional Acne Medication Market, By Therapeutic Class
- 11.3.3.1. Europe Retinoids Market, By Therapeutic Class
- 11.3.3.2. Europe Antibiotics Market, By Therapeutic Class
- 11.3.4 Europe Professional Acne Medication Market, By Formulation
- 11.3.5 Europe Professional Acne Medication Market, By Country
- 11.3.5.1. Uk
- 11.3.5.1.1. Uk Professional Acne Medication Market, By Distribution Channels
- 11.3.5.1.2. Uk Professional Acne Medication Market, By Acne Type
- 11.3.5.1.3. Uk Professional Acne Medication Market, By Therapeutic Class
- 11.3.5.1.3.1. Uk Retinoids Market, By Therapeutic Class
- 11.3.5.1.3.2. Uk Antibiotics Market, By Therapeutic Class
- 11.3.5.1.4. Uk Professional Acne Medication Market, By Formulation
- 11.3.5.2. Germany
- 11.3.5.2.1. Germany Professional Acne Medication Market, By Distribution Channels
- 11.3.5.2.2. Germany Professional Acne Medication Market, By Acne Type
- 11.3.5.2.3. Germany Professional Acne Medication Market, By Therapeutic Class
- 11.3.5.2.3.1. Germany Retinoids Market, By Therapeutic Class
- 11.3.5.2.3.2. Germany Antibiotics Market, By Therapeutic Class
- 11.3.5.2.4. Germany Professional Acne Medication Market, By Formulation
- 11.3.5.3. France
- 11.3.5.3.1. France Professional Acne Medication Market, By Distribution Channels
- 11.3.5.3.2. France Professional Acne Medication Market, By Acne Type
- 11.3.5.3.3. France Professional Acne Medication Market, By Therapeutic Class
- 11.3.5.3.3.1. France Retinoids Market, By Therapeutic Class
- 11.3.5.3.3.2. France Antibiotics Market, By Therapeutic Class
- 11.3.5.3.4. France Professional Acne Medication Market, By Formulation
- 11.3.5.4. Spain
- 11.3.5.4.1. Spain Professional Acne Medication Market, By Distribution Channels
- 11.3.5.4.2. Spain Professional Acne Medication Market, By Acne Type
- 11.3.5.4.3. Spain Professional Acne Medication Market, By Therapeutic Class
- 11.3.5.4.3.1. Spain Retinoids Market, By Therapeutic Class
- 11.3.5.4.3.2. Spain Antibiotics Market, By Therapeutic Class
- 11.3.5.4.4. Spain Professional Acne Medication Market, By Formulation
- 11.3.5.5. Italy
- 11.3.5.5.1. Italy Professional Acne Medication Market, By Distribution Channels
- 11.3.5.5.2. Italy Professional Acne Medication Market, By Acne Type
- 11.3.5.5.3. Italy Professional Acne Medication Market, By Therapeutic Class
- 11.3.5.5.3.1. Italy Retinoids Market, By Therapeutic Class
- 11.3.5.5.3.2. Italy Antibiotics Market, By Therapeutic Class
- 11.3.5.5.4. Italy Professional Acne Medication Market, By Formulation
- 11.3.5.6. Netherlands
- 11.3.5.6.1. Netherlands Professional Acne Medication Market, By Distribution Channels
- 11.3.5.6.2. Netherlands Professional Acne Medication Market, By Acne Type
- 11.3.5.6.3. Netherlands Professional Acne Medication Market, By Therapeutic Class
- 11.3.5.6.3.1. Netherlands Retinoids Market, By Therapeutic Class
- 11.3.5.6.3.2. Netherlands Antibiotics Market, By Therapeutic Class
- 11.3.5.6.4. Netherlands Professional Acne Medication Market, By Formulation
- 11.3.5.7. Rest Of Europe
- 11.3.5.7.1. Rest Of Europe Professional Acne Medication Market, By Distribution Channels
- 11.3.5.7.2. Rest Of Europe Professional Acne Medication Market, By Acne Type
- 11.3.5.7.3. Rest Of Europe Professional Acne Medication Market, By Therapeutic Class
- 11.3.5.7.3.1. Rest Of Europe Retinoids Market, By Therapeutic Class
- 11.3.5.7.3.2. Rest Of Europe Antibiotics Market, By Therapeutic Class
- 11.3.5.7.4. Rest Of Europe Professional Acne Medication Market, By Formulation
- 11.4. Asia-pacific
- 11.4.1 Asia-pacific Professional Acne Medication Market, By Distribution Channels
- 11.4.2 Asia-pacific Professional Acne Medication Market, By Acne Type
- 11.4.3 Asia-pacific Professional Acne Medication Market, By Therapeutic Class
- 11.4.3.1. Asia-pacific Retinoids Market, By Therapeutic Class
- 11.4.3.2. Asia-pacific Antibiotics Market, By Therapeutic Class
- 11.4.4 Asia-pacific Professional Acne Medication Market, By Formulation
- 11.4.5 Asia-pacific Professional Acne Medication Market, By Country
- 11.4.5.1. China
- 11.4.5.1.1. China Professional Acne Medication Market, By Distribution Channels
- 11.4.5.1.2. China Professional Acne Medication Market, By Acne Type
- 11.4.5.1.3. China Professional Acne Medication Market, By Therapeutic Class
- 11.4.5.1.3.1. China Retinoids Market, By Therapeutic Class
- 11.4.5.1.3.2. China Antibiotics Market, By Therapeutic Class
- 11.4.5.1.4. China Professional Acne Medication Market, By Formulation
- 11.4.5.2. Japan
- 11.4.5.2.1. Japan Professional Acne Medication Market, By Distribution Channels
- 11.4.5.2.2. Japan Professional Acne Medication Market, By Acne Type
- 11.4.5.2.3. Japan Professional Acne Medication Market, By Therapeutic Class
- 11.4.5.2.3.1. Japan Retinoids Market, By Therapeutic Class
- 11.4.5.2.3.2. Japan Antibiotics Market, By Therapeutic Class
- 11.4.5.2.4. Japan Professional Acne Medication Market, By Formulation
- 11.4.5.3. India
- 11.4.5.3.1. India Professional Acne Medication Market, By Distribution Channels
- 11.4.5.3.2. India Professional Acne Medication Market, By Acne Type
- 11.4.5.3.3. India Professional Acne Medication Market, By Therapeutic Class
- 11.4.5.3.3.1. India Retinoids Market, By Therapeutic Class
- 11.4.5.3.3.2. India Antibiotics Market, By Therapeutic Class
- 11.4.5.3.4. India Professional Acne Medication Market, By Formulation
- 11.4.5.4. Australia
- 11.4.5.4.1. Australia Professional Acne Medication Market, By Distribution Channels
- 11.4.5.4.2. Australia Professional Acne Medication Market, By Acne Type
- 11.4.5.4.3. Australia Professional Acne Medication Market, By Therapeutic Class
- 11.4.5.4.3.1. Australia Retinoids Market, By Therapeutic Class
- 11.4.5.4.3.2. Australia Antibiotics Market, By Therapeutic Class
- 11.4.5.4.4. Australia Professional Acne Medication Market, By Formulation
- 11.4.5.5. South Korea
- 11.4.5.5.1. South Korea Professional Acne Medication Market, By Distribution Channels
- 11.4.5.5.2. South Korea Professional Acne Medication Market, By Acne Type
- 11.4.5.5.3. South Korea Professional Acne Medication Market, By Therapeutic Class
- 11.4.5.5.3.1. South Korea Retinoids Market, By Therapeutic Class
- 11.4.5.5.3.2. South Korea Antibiotics Market, By Therapeutic Class
- 11.4.5.5.4. South Korea Professional Acne Medication Market, By Formulation
- 11.4.5.6. Taiwan
- 11.4.5.6.1. Taiwan Professional Acne Medication Market, By Distribution Channels
- 11.4.5.6.2. Taiwan Professional Acne Medication Market, By Acne Type
- 11.4.5.6.3. Taiwan Professional Acne Medication Market, By Therapeutic Class
- 11.4.5.6.3.1. Taiwan Retinoids Market, By Therapeutic Class
- 11.4.5.6.3.2. Taiwan Antibiotics Market, By Therapeutic Class
- 11.4.5.6.4. Taiwan Professional Acne Medication Market, By Formulation
- 11.4.5.7. Vietnam
- 11.4.5.7.1. Vietnam Professional Acne Medication Market, By Distribution Channels
- 11.4.5.7.2. Vietnam Professional Acne Medication Market, By Acne Type
- 11.4.5.7.3. Vietnam Professional Acne Medication Market, By Therapeutic Class
- 11.4.5.7.3.1. Vietnam Retinoids Market, By Therapeutic Class
- 11.4.5.7.3.2. Vietnam Antibiotics Market, By Therapeutic Class
- 11.4.5.7.4. Vietnam Professional Acne Medication Market, By Formulation
- 11.4.5.8. Rest Of Asia-pacific
- 11.4.5.8.1. Rest Of Asia-pacific Professional Acne Medication Market, By Distribution Channels
- 11.4.5.8.2. Rest Of Asia-pacific Professional Acne Medication Market, By Acne Type
- 11.4.5.8.3. Rest Of Asia-pacific Professional Acne Medication Market, By Therapeutic Class
- 11.4.5.8.3.1. Rest Of Asia-pacific Retinoids Market, By Therapeutic Class
- 11.4.5.8.3.2. Rest Of Asia-pacific Antibiotics Market, By Therapeutic Class
- 11.4.5.8.4. Rest Of Asia-pacific Professional Acne Medication Market, By Formulation
- 11.5. Rest Of World
- 11.5.1 Rest Of World Professional Acne Medication Market, By Distribution Channels
- 11.5.2 Rest Of World Professional Acne Medication Market, By Acne Type
- 11.5.3 Rest Of World Professional Acne Medication Market, By Therapeutic Class
- 11.5.3.1. Rest Of World Retinoids Market, By Therapeutic Class
- 11.5.3.2. Rest Of World Antibiotics Market, By Therapeutic Class
- 11.5.4 Rest Of World Professional Acne Medication Market, By Formulation
- 11.5.5 Rest Of World Professional Acne Medication Market, By Country
- 11.5.5.1. Latin America
- 11.5.5.1.1. Latin America Professional Acne Medication Market, By Distribution Channels
- 11.5.5.1.2. Latin America Professional Acne Medication Market, By Acne Type
- 11.5.5.1.3. Latin America Professional Acne Medication Market, By Therapeutic Class
- 11.5.5.1.3.1. Latin America Retinoids Market, By Therapeutic Class
- 11.5.5.1.3.2. Latin America Antibiotics Market, By Therapeutic Class
- 11.5.5.1.4. Latin America Professional Acne Medication Market, By Formulation
- 11.5.5.2. Middle East
- 11.5.5.2.1. Middle East Professional Acne Medication Market, By Distribution Channels
- 11.5.5.2.2. Middle East Professional Acne Medication Market, By Acne Type
- 11.5.5.2.3. Middle East Professional Acne Medication Market, By Therapeutic Class
- 11.5.5.2.3.1. Middle East Retinoids Market, By Therapeutic Class
- 11.5.5.2.3.2. Middle East Antibiotics Market, By Therapeutic Class
- 11.5.5.2.4. Middle East Professional Acne Medication Market, By Formulation
- 11.5.5.3. Africa
- 11.5.5.3.1. Africa Professional Acne Medication Market, By Distribution Channels
- 11.5.5.3.2. Africa Professional Acne Medication Market, By Acne Type
- 11.5.5.3.3. Africa Professional Acne Medication Market, By Therapeutic Class
- 11.5.5.3.3.1. Africa Retinoids Market, By Therapeutic Class
- 11.5.5.3.3.2. Africa Antibiotics Market, By Therapeutic Class
- 11.5.5.3.4. Africa Professional Acne Medication Market, By Formulation
- 12. Company Profiles
- 12.1. Almirall S.A.
- 12.1.1 Company Overview
- 12.1.2 Company Snapshot
- 12.1.3 Product Portfolio
- 12.1.4 Business Performance
- 12.1.5 Key Strategic Moves & Developments
- 12.1.6 Primary Market Competitors
- 12.2. Bausch Health Companies Inc.
- 12.2.1 Company Overview
- 12.2.2 Company Snapshot
- 12.2.3 Operating Business Segments
- 12.2.4 Product Portfolio
- 12.2.5 Business Performance
- 12.2.6 Sales By Business Segment
- 12.2.7 Sales By Geographic Segment
- 12.2.8 Key Strategic Moves & Developments
- 12.2.9 Primary Market Competitors
- 12.3. Johnson & Johnson
- 12.3.1 Company Overview
- 12.3.2 Company Snapshot
- 12.3.3 Operating Business Segments
- 12.3.4 Product Portfolio
- 12.3.5 Business Performance
- 12.3.6 Sales By Business Segment
- 12.3.7 Sales By Geographic Segment
- 12.3.8 Key Strategic Moves & Developments
- 12.3.9 Primary Market Competitors
- 12.4. Glaxosmithkline Plc
- 12.4.1 Company Overview
- 12.4.2 Company Snapshot
- 12.4.3 Operating Business Segments
- 12.4.4 Product Portfolio
- 12.4.5 Business Performance
- 12.4.6 Sales By Business Segment
- 12.4.7 Sales By Geographic Segment
- 12.4.8 Key Strategic Moves & Developments
- 12.4.9 Primary Market Competitors
- 12.5. Galderma
- 12.5.1 Company Overview
- 12.5.2 Company Snapshot
- 12.5.3 Product Portfolio
- 12.5.4 Key Strategic Moves & Developments
- 12.5.5 Primary Market Competitors
- 12.6. Mayne Pharma Group Limited
- 12.6.1 Company Overview
- 12.6.2 Company Snapshot
- 12.6.3 Operating Business Segments
- 12.6.4 Product Portfolio
- 12.6.5 Business Performance
- 12.6.6 Sales By Business Segment
- 12.6.7 Sales By Geographic Segment
- 12.6.8 Key Strategic Moves & Developments
- 12.6.9 Primary Market Competitors
- 12.7. Viatris Inc.
- 12.7.1 Company Overview
- 12.7.2 Company Snapshot
- 12.7.3 Operating Business Segments
- 12.7.4 Product Portfolio
- 12.7.5 Business Performance
- 12.7.6 Operating Business Segments
- 12.7.7 Sales By Business Segment
- 12.7.8 Sales By Geographic Segment
- 12.7.9 Key Strategic Moves & Developments
- 12.7.10 Primary Market Competitors
- 12.8. Sun Pharmaceutical Industries Limited
- 12.8.1 Company Overview
- 12.8.2 Company Snapshot
- 12.8.3 Product Portfolio
- 12.8.4 Business Performance
- 12.8.5 Sales By Business Segment
- 12.8.6 Sales By Geographic Segment
- 12.8.7 Key Strategic Moves & Developments
- 12.8.8 Primary Market Competitors
- 12.9. Pfizer Inc.
- 12.9.1 Company Overview
- 12.9.2 Company Snapshot
- 12.9.3 Operating Business Segments
- 12.9.4 Product Portfolio
- 12.9.5 Business Performance
- 12.9.6 Sales By Business Segment
- 12.9.7 Sales By Geographic Segment
- 12.9.8 Key Strategic Moves & Developments
- 12.9.9 Primary Market Competitors
- 12.10. Teva Pharmaceutical Industries Ltd.
- 12.10.1 Company Overview
- 12.10.2 Company Snapshot
- 12.10.3 Product Portfolio
- 12.10.4 Business Performance
- 12.10.5 Sales By Business Segment
- 12.10.6 Sales By Geographic Segment
- 12.10.7 Key Strategic Moves & Developments
- 12.10.8 Primary Market Competitors
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.